THRM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Gentherm Inc (THRM) is not a strong buy at this moment for a beginner investor with a long-term strategy. The mixed financial performance, lack of strong technical signals, and recent downgrades in analyst ratings suggest a cautious approach. Holding the stock or waiting for further clarity on financial and operational improvements is recommended.
The MACD histogram is positive at 0.322, indicating a mild bullish trend, but it is contracting. RSI is neutral at 51.305, showing no clear momentum. Moving averages are converging, suggesting indecision. The current pre-market price of $32.68 is near the pivot level of $32.417, with resistance at $34.317 and support at $30.516. Overall, the technical indicators do not strongly support a buy signal.
Stifel's Buy rating with a $41 price target highlights potential growth opportunities in automotive thermal management and comfort systems, driven by electric vehicle penetration and energy-efficient features. Revenue increased by 8.46% YoY in Q4 2025, showing some top-line growth.
Hedge funds are selling, with a significant increase in selling activity (up 8556.93% last quarter). Financial performance in Q4 2025 was weak, with net income dropping by 80.50% YoY and EPS declining by 79.59% YoY. Gross margin also decreased by 2.79%. Analyst downgrades, including Freedom Capital's downgrade to Hold and Baird's price target reduction to $36, reflect concerns about margin pressure and a transition year.
In Q4 2025, revenue increased by 8.46% YoY to $382.8M, but net income dropped significantly by 80.50% YoY to $2.99M. EPS fell by 79.59% YoY to $0.1, and gross margin declined to 23.72%, down 2.79% YoY. The financials indicate top-line growth but significant bottom-line challenges.
Analyst sentiment is mixed. Stifel initiated coverage with a Buy rating and a $41 price target, citing growth opportunities. However, Freedom Capital downgraded the stock to Hold with a reduced price target of $38, citing margin pressures. Baird also lowered its price target to $36, maintaining a Neutral rating.
